Amryt Pharma Plc (NASDAQ: AMYT), relating to its proposed sale to Chiesi Farmaceutici SpA. Under the terms of the agreement, AMYT shareholders are expected to receive $14.50 plus one Contingent Value Right of up to $2.50 per American Depositary Share they own.